After selling his companys formulations business to US-based Abbott Laboratories for around Rs 17,000 crore a year ago, Ajay Piramal, chairman of , announced PHLs first major diversification roadmap on Friday. PHL will foray into the financial services...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Piramal Healthcare forays into financial services biz
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account